@almuftifawaz @JustinSingerMD @CerebrovascLab @AmeerEHassan @NguyenThanhMD @STateshimaMD @_AdnanSiddiqui @EladLevyMD @PascalJabbourMD @AshuPJadhav @JPTsaiMD 😢

#STROKE Diagnostic Imaging: The CAROTID RING SIGN on single-phased #CTA is a potent imaging marker to differentiate true occlusion from pseudo-occlusion with sensitivity and specificity of 0.70 and 0.94, respectively. #AHAJournals https://t.co/WUd1w8XOvs @jake_sui

#STROKE Topical Review by @a_charidimou & @VCI_EricSmith: Cerebral microbleeds #CMBs in the setting of cerebral amyloid angiopathy #CAA: bleeding risk and safety of antithrombotic management. #AHAJournals https://t.co/PYlJRYWAZu

Second Q&A with Drs. Entazami and Dr. Ramadan, again moderated by Dr. @AlexChebl. Thank you for your incredible insights on the limits of acute stroke care and the medical vs. surgical vs. endovascular management of the carotid web.

⁦@AmyLynnAho⁩ talking at 6th Detroit Stroke Conference about Navigating the Post-Stroke Journey, highlighting the Herculean effort and costs required by patients and their care givers in their recovery post stroke. A real hero! ⁦@HenryFordNeuro⁩ ⁦@RiadRmdn⁩

Honored to welcome Dr Andrew Asimos as the Keynote Speaker at @HenryFordNeuro 6th Annual Detroit Stroke Conference, On his Birthday! @OwaisAlsrouji @aboulnourh @GhadaMohamedMD @RiadRmdn

Fantastic news for carotid stenosis patients who now have more treatment options based on their specific circumstances and personal preferences as CMS decided to cover CAS in non-high risk patients. However, CREST-2 enrollment remains as important as ever

Early Intubation in Endovascular Therapy for Basilar Artery Occlusion: A Post Hoc Analysis of the BASICS Trial | Stroke https://t.co/WrWCEH7UiY

Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials - The Lancet

Our latest in collaboration with @JimSiegler @NguyenThanhMD and co-authors. Acute basilar occlusions presenting with mild deficits based on NIHSS seem to do better with thrombectomy vs. medical treatment alone. https://t.co/gDETE5iVaQ @StrokeAHA_ASA

🗞️Safety & Outcome of Revascularization Treatment in Patients With Acute Stroke & COVID-19: The 🌎Global COVID-19 Stroke Registry 🧠 https://t.co/AtWsVXCzhv Outstanding work led by João Pedro Marto, @DStrambo @GeorgeNtaios Patrik Michel @CHUVLausanne with our 🌎 colleagues⬇️

TIMELESS trial shows no benefit of TNK in the extended time window of 4.5-24 hours of LKW among patients with ICA/M1/M2 occlusion did not show benefit on the 90-day mRS without any signal of safety concerns. #ESOC2023

A phase II randomized trial of Trendelenburg position for acute moderate ischemic stroke. https://t.co/STLp8AQDAO led by Hui-Sheng Chen et al.

We are thrilled to welcome our new Chairman of Neurology, Dr. Brien J. Smith (Pictured here with Dr. Steven N. Kalkanis, Chairman, Henry Ford Medical Group). Read more about Dr. Smith here: https://t.co/20aHGUGAIQ @SteveKalkanisMD @HenryFordHealth

ARAMIS Open label RCT DAPT vs tPA in Chinese minor stroke (NIHSS<6): median NIHSS 2. DAPT non-inferior with lower risk of deterioration and lower bleeding events. Higher NIHSS may be better w tPA. This is big deal #ISC23 @HenryFordNeuro @OwaisAlsrouji @GhadaMohamedMD @aboulnourh

"This is about giving #Detroit what every major U.S. city has and deserves: a world-class academic medical center and campus that will change the face - and the delivery - of care as this community knows it." - @SteveKalkanisMD. Details: https://t.co/sPQS2mhyVG

Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct | NEJM

SELECT2 RCT for large core: median ASPECTS 4 and inf core 80cc. NNT for benefit of 4.94. OR 1.51 for benefit. sICH 0.6% vs 1.1%. #ISC23 @HenryFordNeuro @OwaisAlsrouji @GhadaMohamedMD @aboulnourh @WBrinjikji

ANGEL-ASPECT RCT of EVT for large core <24hrs: stop early for EFFICACY! Median ASPECTS 3 & inf vol 60-63cc. Benefit all subgroups. sICH 6.1% vs2.7%. No diff in mortality. Less sleep for us, less disability for pts #ISC23 @HenryFordNeuro @OwaisAlsrouji @GhadaMohamedMD @aboulnourh

CATIS2 RCT early or delayed BP control post AIS (without IVT or EVT) no diff in 90d mRS #ISC23 @HenryFordNeuro @stephanamayer @OwaisAlsrouji @GhadaMohamedMD @aboulnourh